Access cutting-edge non-small cell lung cancer treatment through this clinical trial at a research site in Redlands. Study-provided care at no cost to qualified participants.
Access non-small cell lung cancer specialists in Redlands at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-small cell lung cancer treatment provided free
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the first-line (1L) treatment of patients with metastatic squamous non-small cell lung cancer (mNSCLC) whose tumors express programmed death-ligand 1 (PD-L1).
Sponsor: AstraZeneca
Check if you qualify for this non-small cell lung cancer clinical trial in Redlands, CA
If you're searching for non-small cell lung cancer treatment options in Redlands, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Redlands research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.